Company intelligence / Profile preview

ConBio

Fremont, California, USA

Ownership: Private
Development stage: Other

Overview

ConBio, originally founded as Continuum Biomedical, is a prominent medical device company specializing in high-end Q-switched laser systems for the aesthetic and surgical markets. The company is widely recognized for its MedLite and RevLite product lines, which are considered industry standards for tattoo removal and the treatment of pigmented lesions. Acquired by Cynosure in 2011, ConBio's technology has been integrated into a broader portfolio of aesthetic solutions, continuing to serve dermatologists and plastic surgeons worldwide. Its products utilize advanced laser technology to provide versatile, reliable, and non-invasive treatments for various skin conditions and aesthetic enhancements.

Therapeutic areas: CardiovascularDermatology
Modalities: DeviceLaser technology
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on ConBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ConBio.

Explore the full profile